4,5-Dibromo-2-(3,3-dimethyl-2-oxobutyl)-2,3-dihydropyridazin-3-one

Catalog No.: 
ACZTAC037
CAS No.: 
303987-65-7
Molecular Formula: 
C10H12Br2N2O2
Molecular Weight: 
352.03
4,5-Dibromo-2-(3,3-dimethyl-2-oxobutyl)-2,3-dihydropyridazin-3-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg90%$107.00InquiryInquiry
1g90%$323.00InquiryInquiry
5g90%$1599.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4,5-Dibromo-2-(3,3-dimethyl-2-oxobutyl)-2,3-dihydropyridazin-3-one
IUPAC Name4,5-dibromo-2-(3,3-dimethyl-2-oxobutyl)pyridazin-3(2H)-one
Molecular FormulaC10H12Br2N2O2
Molecular Weight352.03
SMILESO=C1C(Br)=C(Br)C=NN1CC(C(C)(C)C)=O
InChI KeyDMLROGGDQNEWBV-UHFFFAOYSA-N
Synonym4,5-DIBROMO-2-(3,3-DIMETHYL-2-OXOBUTYL)-3(2H)-PYRIDAZINONE;4,5-dibromo-2-(3,3-dimethyl-2-oxobutyl)-2,3-dihydropyridazin-3-one;3(2H)-Pyridazinone, 4,5-dibromo-2-(3,3-dimethyl-2-oxobutyl)-;4,5-DIBROMO-2-(3,3-DIMETHYL-2-OXO-BUTYL)-2H-PYRIDAZIN-3-ONE
CAS No.303987-65-7

Synthetic Route by SureRoute

1. ACZTAC037 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACOEFY632 route compound structure diagram
    ACOEFY6325788-58-9In Stock
  4. Then
  5. ACZTAC037 route product structure diagram
    ACZTAC037303987-65-7
Inquiry

2. ACZTAC037 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACOEFY632 route compound structure diagram
    ACOEFY6325788-58-9In Stock
  4. Then
  5. ACZTAC037 route product structure diagram
    ACZTAC037303987-65-7
Inquiry

3. ACZTAC037 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZTAC037 route product structure diagram
    ACZTAC037303987-65-7
Inquiry

Comments (0)